Three SARS-CoV-2 vaccines have now been fast tracked for development by the FDA. The Oxford group, CanSino Biologics and now also Moderna Pharmaceuticals have all had their experimental vaccines approved to move into Phase II trials. This means that they will begin enrolling subject participants in the coming weeks. This
This post was originally published by Whitley Strieber on . Please visit the original post to read the complete article.